A 43-year-old man presented with a pigmented lesion on the left earlobe. Histologic evaluation of a biopsy specimen demonstrated lentigo maligna. The patient was referred to our institution for micrographic excision of the lesion.
A 56-year-old man presented with a pigmented lesion on the right preauricular cheek. A biopsy specimen demonstrated lentigo maligna. The lesion was excised in a standard fashion with 0.5-cm margins. Histologic evaluation of the excised specimen showed persistence of the tumor at the surgical margin. A second attempt at excision failed to fully excise the tumor. The patient was referred to our institution for micrographic excision of the residual tumor.
Successful micrographic excision of lentigo maligna is hindered by difficulty interpreting frozen sections stained with hematoxylin-eosin (HE).
The lentigo maligna was excised using Mohs micrographic excision starting with 0.5-cm margins. In addition to HE staining, frozen sections were stained with the immunohistochemical stain Mel-5. To differentiate true lentigo maligna from surrounding sun-damaged skin, a sample was obtained from the contralateral earlobe to serve as a negative control. A sample from the center of the tumor served as a positive control. Representative sections are shown in Figure 1. One stage was required to clear the tumor. The patient remained tumor free for 15 months.
Left column, Melanocytes are difficult to distinguish (hematoxylin-eosin, ×200). Right column, Melanocytes are readily identified (Mel-5, ×200). Top row, surgical margin. Middle row, Positive control from center of surgical specimen. Bottom row, Negative control from contralateral body site.
The residual tumor was excised using Mohs micrographic excision, starting with 0.5-cm margins. In addition to HE, frozen sections were stained with Mel-5. Positive and negative controls were also obtained as described above. One stage was required to clear the tumor. The patient has remained tumor free for 16 months.
Opinion is divided among dermatologic surgeons as to whether micrographic excision of melanoma is appropriate management,1- 5 particularly whether interpretation of frozen sections stained with HE is reliable. For micrographic excision of melanoma to be successful and practical, the following 4 criteria must be met: (1) the tumor cells must be visually identifiable in the sections; (2) the tumor must be contiguous to avoid false negative-margins; (3) the mapping and staining component must be technically feasible, preferably in the surgeon's own laboratory; and (4) the total tissue processing time should be short enough to allow for a staged excision and repair on the same day.
Most surgeons who advocate micrographic excision of melanoma use HE staining of frozen sections because the technique is simple and familiar.3,4 However, those who oppose micrographic excision of melanoma feel it is difficult to accurately visualize the tumor using HE, especially at the tumor margins where single cells tend to predominate over nests of cells.2 Some authors advocate standard excision or staged excision with "rush permanent" paraffin-embedded sections.2,6 In paraffin-embedded sections, the clues to identifying melanocytes include the retraction artifact, which leaves a vacuolated space between the melanocyte and the surrounding keratinocytes, and the nuclear structure.
No stain can reliably differentiate between melanoma cells and benign melanocytes; however, one that reliably stains all melanocytes and the epidermal components of melanoma allows for diagnosis based on pattern recognition.
Mel-5 is a murine IgG antibody against a 75-kd protein that may be tyrosine-related protein (TRP-1).7- 9 The antigen appears to be particularly expressed in association with stage III and IV melanosomes.8 Epidermal melanocytes and the epidermal component of nevi and of melanomas are readily stained.10,11 The stain may be performed on frozen sections, as well as paraffin-embedded tissue. Our staining protocol (Table 1) requires 75 minutes, thus allowing for a multistaged excision and repair in the same day. The technique is simple and requires little extra equipment other than the antibody and a detection kit. Melanocytes stained with Mel-5 appear as heterochromatic dendritic cells. Compared with other immunohistochemical stains, Mel-5 is superior for this purpose because it so reliably stains epidermal melanocytes and melanoma cells.10 We feel that the best indication for micrographic excision with Mel-5 is for lentigo maligna, because of the superior ability to visualize the tumor and the irregular melanocytes at the margin. In addition, Mel-5 is indicated for micrographic excision of invasive melanoma to allow narrower margins in functionally or cosmetically critical locations. It is important to note that Mel-5 may not reliably stain amelanotic melanoma, desmoplastic melanomas, or the dermal component of melanomas.10 In our practice, we start with a 5-mm margin around the visible margin of the tumor as seen under examination with a Wood light. We employ standard micrographic mapping techniques to orient and section the tissue. Finally, we stain our sections with Mel-5, and often with HE as well. We use a section of tumor from the center of the lesion as a positive control, and often take a small biopsy specimen from the skin from the contralateral body site to serve as a negative control.
In summary, we have presented 2 cases of lentigo maligna micrographically excised using Mel-5 for margin control. The use of Mel-5 on frozen sections is more effective for visualizing residual tumor and normal melanocytes than HE.
The authors have no financial involvement in any of the materials used herein. Some of the materials in this study (Mel-5 antibody, ultrastreptavidin detection kit) were provided free of charge by the manufacturer (Signet Laboratories, Dedham, Mass).
Thank you for submitting a comment on this article. It will be reviewed by JAMA Dermatology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 28
Customize your page view by dragging & repositioning the boxes below.
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.